An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: IKT-001
DRUG: Placebo

Sponsor

Inhibikase Therapeutics